I now have all the material needed for a comprehensive comparison. Here is the full structured response:
Myocarditis vs. Myocardial Infarction
1. Core Definition
| Myocarditis | Myocardial Infarction (MI) |
|---|
| Essence | Inflammation of the myocardium - infectious, immune, or toxic | Ischemic necrosis of myocardium from arterial occlusion |
| Primary mechanism | Immune/inflammatory injury to myocytes | Oxygen supply-demand mismatch due to plaque rupture + thrombosis |
| Vessels | Normal coronary arteries (usually) | Atherosclerotic coronary artery occlusion |
2. Pathogenesis
Myocarditis
The most common cause in the US is viral infection - coxsackie B viruses and enteroviruses predominate historically; more recently parvovirus B19, HHV-6, SARS-CoV-2, and HIV are increasingly implicated. Injury occurs via two mechanisms:
- Direct viral cytotoxicity - viral proteins disrupt sarcolemmal integrity
- Immune-mediated injury - virus-specific T cells attack infected myocytes; molecular mimicry can trigger cross-reactive immune response against myosin heavy chain
Three disease stages have been proposed:
- Acute - cytotoxicity, focal necrosis
- Subacute - humoral autoimmune injury
- Chronic - diffuse fibrosis, dilated cardiomyopathy (DCM) in up to 16% of adults, 46% of children
Non-viral causes include Trypanosoma cruzi (Chagas disease - endemic in Latin America, ~300,000 infected in the US), Toxoplasma, Lyme disease (Borrelia - presents mainly as AV block), drug hypersensitivity, SLE, polymyositis, and post-mRNA COVID-19 vaccination (rare, mainly young males after the second dose, usually self-limited).
Myocardial Infarction
The vast majority are caused by acute coronary thrombosis overlying a disrupted or eroded atherosclerotic plaque. The sequence:
- Plaque erosion/rupture exposes subendothelial collagen and necrotic plaque contents
- Platelets adhere and release TXA2, ADP, serotonin - further aggregation and vasospasm
- Coagulation activation via tissue factor
- Complete luminal occlusion within minutes
In ~10% of MIs, occlusive atherosclerosis is absent - causes include coronary vasospasm, emboli from mural thrombi (e.g. AF), valve vegetations, small vessel vasculitis, amyloid deposition, or sickle cell disease. Within 4 hours, angiography shows thrombosis in ~90% of STEMI cases.
Necrosis begins subendocardially (most distal from epicardial vessels) and expands outward as a wavefront - Robbins & Kumar Basic Pathology
3. Who Gets It? (Epidemiology)
| Myocarditis | MI |
|---|
| Age | Young (teens-40s); no strong age predilection | Risk rises progressively with age; 45% occur before age 65 |
| Sex | Males more common (especially post-vaccine myocarditis) | Men > women; gap narrows after menopause |
| Risk factors | Viral illness, autoimmune disease, immunosuppression, drug exposure | Atherosclerosis risk factors (HTN, DM, dyslipidemia, smoking, family history) |
| Prodrome | Flu-like symptoms (fever, myalgias, fatigue) 1-2 weeks prior | Usually none; or unstable angina prodrome |
4. Clinical Presentation
| Feature | Myocarditis | MI |
|---|
| Chest pain | Variable; pleuritic or positional component possible | Severe, crushing, pressure-like; radiates to arm/jaw |
| Fever | Common | Absent (mild inflammatory fever may occur 24-48h post-MI) |
| Dyspnea | Common (especially in children) | Present if significant LV dysfunction |
| Palpitations/arrhythmias | Prominent - PVCs, NSVT, AV block | Present - VF most feared early complication |
| Hemodynamic instability | Can be fulminant, especially in infants | Cardiogenic shock in large STEMI |
| Prodrome | Flu-like illness precedes by days-weeks | Typically absent or pre-existing angina |
Key clinical clue from Rosen's Emergency Medicine: "Patients with myocarditis are usually young and have few risk factors for coronary artery disease. In myocarditis, chest pain continues without evolving ischemic ECG changes."
5. ECG Findings
| Myocarditis | MI |
|---|
| Pattern | Non-specific; sinus tachycardia, low voltages, prolonged QT, widened QRS | Evolving pattern: hyperacute T waves → ST elevation → Q waves → T inversion |
| ST changes | Diffuse or multifocal ST changes (not following one coronary territory) | ST changes in specific coronary territory (e.g. II/III/aVF for inferior MI) |
| AV block | Can occur (especially in Lyme, Chagas) | Can occur in inferior MI (RCA occlusion) |
| Key distinction | ECG abnormalities may extend beyond the distribution of a single coronary artery | Changes localized to one vascular territory |
| Q waves | Absent | Develop in STEMI (transmural necrosis) |
6. Biomarkers
Both conditions elevate troponin - this is a common pitfall.
| Myocarditis | MI |
|---|
| Troponin | May be elevated (timing uncertain; negative serial troponin does NOT rule out) | Rises 2-4h, peaks 48h, remains elevated 7-10 days |
| CK-MB | May be elevated | Rises 2-4h, peaks 24-48h, normalizes ~72h |
| Pattern | Scattered, unpredictable | Predictable rise-and-fall kinetics |
| Inflammatory markers | ESR/CRP/WBC often elevated, but of no specific diagnostic value | Mild elevation post-MI (inflammatory response) |
Biomarker kinetics in MI - Robbins & Kumar Basic Pathology
7. Echocardiography
| Myocarditis | MI |
|---|
| Wall motion | Global hypokinesis (diffuse, not matching a coronary territory) | Regional wall motion abnormality (territory-specific) |
| EF | Often reduced | Reduced in proportion to infarct size |
| Distinguishing feature | Wall motion abnormalities do NOT follow coronary artery anatomy | Wall motion abnormalities ARE in a coronary artery distribution |
| Pericardial effusion | Can be present (myopericarditis) | Rare (Dressler syndrome, days-weeks post-MI) |
8. Advanced Imaging: Cardiac MRI (CMR)
CMR is the most powerful non-invasive tool for differentiation:
| CMR Finding | Myocarditis | MI |
|---|
| Late gadolinium enhancement (LGE) pattern | Patchy, mid-wall or epicardial, non-coronary distribution; often septal | Subendocardial or transmural, following a coronary territory |
| T2 signal (edema) | Diffuse or patchy myocardial edema | Edema in area at risk (territory-specific) |
| Microvascular obstruction | Absent | Present in large STEMIs ("no-reflow") |
| Prognostic role | Septal/mid-wall LGE predicts SCD and VT risk | Infarct size predicts HF and mortality |
9. Coronary Angiography
- Myocarditis: Normal coronary arteries (key diagnostic finding when coronary disease is suspected)
- MI: Culprit lesion with plaque rupture and thrombus; angiography demonstrates thrombotic occlusion in ~90% of STEMIs within 4 hours
10. Histopathology
Myocarditis (Dallas Criteria)
Formal diagnosis requires endomyocardial biopsy showing:
- Interstitial mononuclear (lymphocytic) infiltrate
- Myocyte injury/necrosis adjacent to the infiltrate
- Edema and hemorrhage in active disease
- No ischemic pattern - not subendocardial-predominant
Viral myocarditis: diffuse lymphocytic infiltrate with myocyte necrosis - Rosen's Emergency Medicine
Myocardial Infarction
Follows a predictable temporal sequence of morphological changes:
| Time | Gross | Microscopy |
|---|
| 0-4h | None | Waviness of fibers at border |
| 4-12h | Occasional dark mottling | Coagulative necrosis, edema, hemorrhage begins |
| 12-24h | Dark mottling | Ongoing coagulation necrosis; pyknosis; early neutrophils |
| 1-3 days | Mottling with yellow center | Neutrophilic infiltrate; loss of nuclei and striations |
| 3-7 days | Hyperemic border, yellow-tan center | Dead myofibers; macrophage infiltration begins |
| 7-10 days | Maximally yellow-tan, soft | Granulation tissue at margins |
| Weeks | White scar forming | Progressive fibrosis |
Key: coagulative necrosis (not liquefactive), subendocardial predilection, neutrophil-then-macrophage-then-fibrosis sequence. Myocardial necrosis proceeds to scar without significant regeneration.
11. Complications
| Myocarditis | MI |
|---|
| Acute | Arrhythmias, AV block, fulminant heart failure, cardiogenic shock, SCD | VF/VT (80-90% of cardiac deaths in acute phase), pump failure, mechanical complications (free wall rupture, papillary muscle rupture, VSD) |
| Chronic | Dilated cardiomyopathy (16% adults, 46% children), persistent VT circuits from scar, SCD | LV aneurysm, Dressler syndrome, chronic HF, recurrent ischemia |
| SCD in young | Myocarditis is among the top causes of SCD in patients <21 years | CAD is top cause in patients >30 years |
12. Management
| Myocarditis | MI |
|---|
| Specific therapy | Supportive; treat underlying cause (antivirals if applicable, immunosuppression in autoimmune forms) | Urgent reperfusion - thrombolysis or PCI (STEMI); antithrombotic therapy |
| HF management | ACEi, diuretics, beta-blockers | ACEi, beta-blockers, aldosterone antagonists, diuretics |
| Activity | Restrict exercise (risk of SCD during myocarditis) | Graduated cardiac rehabilitation |
| Arrhythmia | Beta-blockers, amiodarone; consider ICD after recovery if EF remains low | ICD if EF <35% at 40 days post-MI |
| Transplant | In refractory fulminant myocarditis | In end-stage ischemic cardiomyopathy |
13. Quick Differentiation Summary
| Clue | Points to Myocarditis | Points to MI |
|---|
| Age | Young (teens-40s) | Older; cardiovascular risk factors |
| Prodrome | Flu-like illness | None (or angina) |
| Chest pain character | Pleuritic, variable | Crushing, pressure, radiating |
| ECG ST changes | Multi-territory, non-focal | Single coronary territory |
| Echo wall motion | Global, non-territorial | Regional, territorial |
| CMR LGE | Mid-wall/epicardial, patchy | Subendocardial/transmural |
| Coronary angiography | Normal | Culprit lesion/thrombus |
| Biopsy | Lymphocytic infiltrate + myocyte necrosis | Coagulative necrosis, no inflammation initially |
Sources:
- Robbins & Kumar Basic Pathology, Myocardial Infarction (p. 353-359) and Myocarditis (p. 375-376)
- Rosen's Emergency Medicine: Concepts and Clinical Practice, Myocarditis (p. 1119-1120)
- Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Myocarditis and Arrhythmias
- Goldman-Cecil Medicine, Myocarditis and Myocardial Infarction chapters